前收市價 | 0.3500 |
開市 | 0.3500 |
買盤 | 0.2000 |
賣出價 | 0.3000 |
拍板 | 65.00 |
到期日 | 2024-08-16 |
今日波幅 | 0.3500 - 0.3500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 5.4k |
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
BD's (BDX) robust product portfolio raises optimism about the stock.
Patterson Companies' (PDCO) Patterson CarePay+ is likely to improve overall patient care and streamline practice operations.